Treatment of Chlamydia Infection Comparing WC2031 Tablets With Vibramycin
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
Evaluate the clinical efficacy and safety of WC2031 200 mg tablets taken orally once a day
for 7 days versus Vibramycin (doxycycline) 100 mg capsules taken orally twice a day for 7
days, for the treatment of uncomplicated urogenital Chlamydia trachomatis infection. Primary
efficacy endpoint is microbiological cure at Day 28. Safety assessments are adverse events,
changes in vital signs and laboratory test results.